SCHEMBL19748646

SCHEMBL19748646

[C]#CCNC(=O)OCc1ccccc1[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
CYP2C19 P33261 2/20 0.45
POLB P06746 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
ALDH1A1 P00352 7/20 0.44
HTT P42858 1/20 0.44
HPGD P15428 1/20 0.43
PTPN1 P18031 1/20 0.43
TSHR P16473 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LMNA P02545 1/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11051859 0.89 MAOB (0.49) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL6865965 0.86 MAOB (0.51) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL14962141 0.86 MAOB (0.50) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL6121074 0.85 NPC1 (0.53) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL1057908 0.84 MAOB (0.49) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL11964039 0.83 ALDH1A1 (0.49) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL31496023 0.83 MAOB (0.53) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL12089304 0.83 MAOB (0.53) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL793834 0.82 ALDH1A1 (0.47) MAOBMEN1KMT2ANPC1RAB9A
SCHEMBL29790025 0.82 ALDH1A1 (0.47) MAOBMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023240202-A2 MODIFIED TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE POLYMERASES ANSA BIOTECHNOLOGIES, INC. (US) 2023-12-14 WO disclosed
EP-4276198-A2 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES The Regents of The University of California Santa Cruz (US) 2023-11-15 EP disclosed
EP-3825412-B1 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES UNIV CALIFORNIA (US) 2023-08-30 EP disclosed
US-11732283-B2 Nucleic acid synthesis and sequencing using tethered nucleoside triphosphates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-08-22 US disclosed
WO-2023115047-A2 COMPOSITIONS FOR ENZYMATIC POLYNUCLEOTIDE SYNTHESIS AND METHODS OF USE ANSA BIOTECHNOLOGIES, INC. (US) 2023-06-22 WO disclosed
WO-2023115040-A2 METHODS OF POLYNUCLEOTIDE SYNTHESIS ANSA BIOTECHNOLOGIES, INC. (US) 2023-06-22 WO disclosed
US-11624079-B2 Polymerase-tethered nucleotides for nucleic acid synthesis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-04-11 US disclosed
US-20220205008-A1 Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-06-30 US disclosed
US-11254961-B2 Polymerase-tethered nucleoside triphosphates for use in nucleic acid synthesis THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 US disclosed
EP-3825412-A1 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES The Regents of The University of California (US) 2021-05-26 EP disclosed
EP-3475450-B1 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES UNIV CALIFORNIA (US) 2020-12-09 EP disclosed
EP-3475450-A1 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES The Regents of The University of California (US) 2019-05-01 EP disclosed
US-20190112627-A1 Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-04-18 US disclosed
WO-2017223517-A1 NUCLEIC ACID SYNTHESIS AND SEQUENCING USING TETHERED NUCLEOSIDE TRIPHOSPHATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11624079-B2 Polymerase-tethered nucleotides for nucleic acid synthesis RNGTT, POLN, POLM MAOB 1577/4885MEN1 3059/4885KMT2A 1288/4885
US-20220205008-A1 Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates RNGTT, DNTT, TYMP MAOB 1666/4885MEN1 2192/4885KMT2A 985/4885
US-11254961-B2 Polymerase-tethered nucleoside triphosphates for use in nucleic acid synthesis RNGTT, POLN, TYMP MAOB 1480/4885MEN1 2981/4885KMT2A 1194/4885
US-11732283-B2 Nucleic acid synthesis and sequencing using tethered nucleoside triphosphates RNGTT, DNTT, TYMP MAOB 1666/4885MEN1 2192/4885KMT2A 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.